eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinal vein occlusion |
| Symptom | |macular edema |
| Sentences | 187 |
| PubMedID- 24515951 | In patients with macular edema due to retinal vein occlusion, intraocular il-18 levels increased significantly (p < 0.001) after treatment with ranibizumab particularly in patients with high baseline il-18 which correlated with good visual outcome (p < 0.05). |
| PubMedID- 26305536 | Purpose: to investigate regional changes in choroidal thickness in branch retinal vein occlusion (brvo) patients with macular edema. |
| PubMedID- 20531142 | Conclusion: individualized repeated intravitreal injections of ranibizumab showed promising short-term results in visual acuity improvement and decrease in cft in patients with macular edema associated with branch retinal vein occlusion. |
| PubMedID- 25411827 | Purpose: dexamethasone intravitreal implant (dex implant, ozurdex((r)); allergan, inc.) is used to treat noninfectious posterior uveitis and macular edema associated with retinal vein occlusion and diabetic retinopathy. |
| PubMedID- 22653439 | Background: to evaluate the baseline spectral-domain optical coherence tomography (sd-oct) characteristics of macular edema (me) due to branch retinal vein occlusion (brvo) for visual outcome after intravitreal bevacizumab injection. |
| PubMedID- 20738886 | Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study. |
| PubMedID- 26383643 | Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels. |
| PubMedID- 23598674 | Twelve-month experience with ozurdex for the treatment of macular edema associated with retinal vein occlusion. |
| PubMedID- 25223207 | Subjects and methods: twenty seven eyes of 27 patients who had undergone vitrectomy for macular edema associated with branch retinal vein occlusion (brvo), proliferative diabetic retinopathy (pdr), macular hole (mh)/epiretinal membrane (erm) at toho university sakura medical center were studied. |
| PubMedID- 22739239 | Purpose: to compare the efficacy and safety of three intravitreal bevacizumab upload injections followed by a dexamethasone implant versus dexamethasone implant monotherapy in eyes with macular edema due to retinal vein occlusion. |
| PubMedID- 22044337 | Rapid resolution of macular edema associated with central retinal vein occlusion using ranibizumab after failure with multiple bevacizumab injections. |
| PubMedID- 26109021 | Early results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusion. |
| PubMedID- 21811207 | Three treatments for macular edema because of branch retinal vein occlusion: intravitreous bevacizumab or tissue plasminogen activator, and vitrectomy. |
| PubMedID- 24876761 | Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion. |
| PubMedID- 22183139 | Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab. |
| PubMedID- 24311895 | Ranibizumab is now fda approved for the treatment of age-related macular degeneration as well as macular edema associated with retinal vein occlusion. |
| PubMedID- 22553416 | The formation of lmh has been described in patients with diabetic cystoid edema and in chronic cystoid macular edema associated with retinal vein occlusion. |
| PubMedID- 21402982 | An eye from 8 patients diagnosed as having macular edema due to branch retinal vein occlusion received an injection, after having received topical anesthesia, of 0.2 ml of ape, which had been obtained using a simplified method. |
| PubMedID- 20703046 | Laser photocoagulation in a 'grid' pattern over the area, demonstrated as leaking by fa, remains the 'reference treatment for macular edema due to branch retinal vein occlusion', according to the recent results of the score trial. |
| PubMedID- 23411880 | Objective: to evaluate the association between vitreous fluid levels of inflammatory factors and macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 24828198 | Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections. |
| PubMedID- 24402616 | Purpose: to investigate the association between vitreomacular adhesion (vma) and the visual and anatomic outcomes of antivascular endothelial growth factor therapy for macular edema due to branch retinal vein occlusion (brvo). |
| PubMedID- 22615698 | Resolution of persistent cystoid macular edema due to central retinal vein occlusion in a vitrectomized eye following intravitreal implant of dexamethasone 0.7 mg. |
| PubMedID- 24205253 | The geneva (global evaluation of implantable dexamethasone in retinal vein occlusion with macular edema) study evaluated the safety and efficacy of an intravitreal dexamethasone implant 0.7 mg versus an implant 0.35 mg versus sham injection in both brvo and crvo. |
| PubMedID- 21500185 | Results: nine eyes of 9 consecutive patients treated with a total of 9 sustained-release dexamethasone 0.7 mg intravitreal implants for macular edema associated with retinal vein occlusion were included. |
| PubMedID- 24741610 | It was approved by the fda for the treatment of neovascular amd, macular edema associated with retinal vein occlusion, and since 2012, it is approved for the treatment of dme . |
| PubMedID- 22991926 | Retinal function and morphology in central retinal vein occlusion with macular edema. |
| PubMedID- 24778755 | Branch retinal vein occlusion with sectoral cystoid macular edema in toxoplasmic chorioretinitis. |
| PubMedID- 21337043 | Sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (report 1). |
| PubMedID- 25885285 | Background: dexamethasone intravitreal implant (dex implant) is a sustained-release biodegradable implant approved for treatment of macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 21383939 | The dexamethasone implant is now emerging as a potential treatment for macular edema arising from retinal vein occlusion, diabetic retinopathy, and uveitis. |
| PubMedID- 23690676 | Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report. |
| PubMedID- 26335912 | Purpose: our aim was to investigate predictive factors associated with efficacy and recurrence after intravitreal bevacizumab (ivb) therapy for macular edema (me) in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 23483492 | Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting. |
| PubMedID- 23224127 | Purpose: the aim of this study was to evaluate the effects of intravitreal treatment with bevacizumab (ivb) compared with triamcinolone (ivt) in patients with macular edema due to branch retinal vein occlusion (brvo) depending on the duration of brvo. |
| PubMedID- 26285577 | Conclusion: the possibility of an infrequent complication like macular hole should be considered for intravitreal ranibizumab for macular edema with branch retinal vein occlusion. |
| PubMedID- 21211297 | Objective: to study the correlation of visual acuity and photoreceptor in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion (brvo). |